Follow the 케어젠 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 케어젠 has published 76 insider filings. Market capitalisation: €2,844.3bn. The latest transaction was disclosed on 27 May 2026 (Purchase). Among the most active insiders: 정용지. All data is free.
74
Insider Decl.
n/a
Thresholds
€603,655
46 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
Buys €603,655n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,238 of 28,021 companies
63.5
score / 100
Value
39
Quality
88
FCF yld0.4%
Earn yld0.6%
EV/EBITDA·
ROE·
Gross mgn72%
Net mgn28%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Caregen is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for consumer health and wellness.